Ameriprise Financial Inc. increased its position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 531,354 shares of the company's stock after buying an additional 69,550 shares during the quarter. Ameriprise Financial Inc. owned 0.18% of Stevanato Group worth $11,578,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in STVN. First Bank & Trust grew its holdings in Stevanato Group by 7.3% in the 4th quarter. First Bank & Trust now owns 15,145 shares of the company's stock worth $330,000 after acquiring an additional 1,036 shares during the last quarter. Truist Financial Corp grew its stake in shares of Stevanato Group by 4.2% in the fourth quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after purchasing an additional 1,073 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Stevanato Group by 9.7% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company's stock valued at $281,000 after purchasing an additional 1,141 shares during the period. US Bancorp DE raised its position in Stevanato Group by 17.9% during the 4th quarter. US Bancorp DE now owns 8,527 shares of the company's stock valued at $186,000 after purchasing an additional 1,295 shares during the last quarter. Finally, Advisors Capital Management LLC raised its position in Stevanato Group by 1.0% during the 4th quarter. Advisors Capital Management LLC now owns 170,776 shares of the company's stock valued at $3,721,000 after purchasing an additional 1,735 shares during the last quarter.
Stevanato Group Stock Down 1.6%
Shares of STVN traded down €0.37 ($0.42) on Friday, reaching €22.24 ($25.27). The stock had a trading volume of 159,500 shares, compared to its average volume of 343,538. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.82) and a 12-month high of €25.75 ($29.26). The firm has a market capitalization of $6.74 billion, a price-to-earnings ratio of 47.32, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51. The company has a 50-day simple moving average of €21.72 and a 200-day simple moving average of €21.32.
Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share (EPS) for the quarter, hitting the consensus estimate of €0.20 ($0.23). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million during the quarter, compared to analyst estimates of €346.26 million. Sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 EPS for the current year.
Stevanato Group Increases Dividend
The business also recently declared an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be given a $0.0613 dividend. This is a boost from Stevanato Group's previous annual dividend of $0.05. This represents a dividend yield of 0.3%. The ex-dividend date is Thursday, June 5th. Stevanato Group's payout ratio is currently 11.76%.
Analyst Ratings Changes
STVN has been the topic of several research analyst reports. William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. Finally, UBS Group decreased their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of €25.70 ($29.20).
Get Our Latest Report on STVN
About Stevanato Group
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
